Prelude Therapeutics, Inc. (PRLD)
1.66
+0.01
(+0.61%)
USD |
NASDAQ |
Dec 11, 13:18
Prelude Therapeutics Market Cap: 104.36M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 18.79B |
| Nautilus Biotechnology, Inc. | 258.93M |
| Protalix Biotherapeutics, Inc. | 145.56M |
| ALX Oncology Holdings, Inc. | 84.04M |
| Erasca, Inc. | 970.29M |
Market Cap Related Metrics
| PS Ratio | 11.20 |
| Price to Book Value | 1.783 |
| Price | 1.66 |
| Earnings Yield | -97.19% |